FMCQF (Fresenius Medical Care AG) ROCE %: 4.83% (As of Mar. 2026)


FMCQF Fresenius Medical Care AG FMCQF
72 GF Score
Price $45.17
GF Value $47.43
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG ROCE %?

Fresenius Medical Care AG FMCQF 72 ROCE % is 4.83% as of Mar. 2026. GuruFocus rates FMCQF with a GF Score™ of 72/100 and a GF Value™ of $47.43 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fresenius Medical Care AG's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.83%.

Fresenius Medical Care AG  (OTCPK:FMCQF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Fresenius Medical Care AG ROCE % Related Terms

Fresenius Medical Care AG ROCE % Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG ROCE % Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.04 5.43 5.18 5.15 7.63

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.10 6.99 7.88 9.73 4.83
FMCQF
72GF Score
Fresenius Medical Care AG FMCQF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG ROCE % Calculation

Fresenius Medical Care AG's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=2220.898/( ( (35148.25 - 5926.764) + (36302.498 - 7312.767) )/ 2 )
=2220.898/( (29221.486+28989.731)/ 2 )
=2220.898/29105.6085
=7.63 %

Fresenius Medical Care AG's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=1391.056/( ( (36302.498 - 7312.767) + (36378.72 - 7779.792) )/ 2 )
=1391.056/( ( 28989.731 + 28598.928 )/ 2 )
=1391.056/28794.3295
=4.83 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.83% mean?
Fresenius Medical Care AG (FMCQF) has a ROCE % of 4.83% as of Mar. 2026.
Is Fresenius Medical Care AG's ROCE % too high?
Fresenius Medical Care AG's current ROCE % is 4.83%. The Healthcare Providers & Services industry median ROCE % is 6.41. Fresenius Medical Care AG's value of 4.83% is 24.6% below this industry median. Overall, Fresenius Medical Care AG has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's ROCE % compare to HCA and THC?
Fresenius Medical Care AG's ROCE % of 4.83% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Fresenius Medical Care AG's value of 4.83% is 24.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current ROCE % of 4.83% is 24.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current ROCE % is 4.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMCQF) is currently considered Fairly Valued. The stock's GF Value™ is $47.43, compared to a current price of $45.17 — trading 4.8% below its estimated fair value. The current ROCE % is 4.83% and 24.6% below the Healthcare Providers & Services industry median of 6.41. Fresenius Medical Care AG's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Fresenius Medical Care AG (FMCQF), the current ROCE % is 4.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (FMCQF) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of $45.17 is trading 4.8% below its estimated GF Value™ of $47.43. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for FMCQF:

  • ROCE %: 4.83%
  • GF Value™: $47.43 vs. price of $45.17 (4.8% below fair value)
  • GF Score™: 72/100 with 4 warning signs
  • Industry Position: 24.6% below the Healthcare Providers & Services median

No single metric tells the full story. See the FMCQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
72GF Score

Get the complete analysis for FMCQF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.17
Price
$47.43
GF Value